Timothy P Noyes Aerovate Therapeutics, Inc. (AVTE) insider trading activity

Timothy P Noyes is CHIEF EXECUTIVE OFFICER of Aerovate Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AVTE, which is worth approximately $0. The most recent transaction as insider was on May 16, 2024, when has been sold 10,000 shares (Common Stock) at a price of $21.72 per share, resulting in proceeds of $217,200. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

0% 3M change

0% 12M change

Total Value Held $0

TIMOTHY P NOYES Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
May 16 2024	SELL Open market or private sale	$217,200 $21.72 p/Share	10,000 Reduced 100.0%	0 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	$21,400 $2.14 p/Share	10,000 Added 50.0%	10,000 Common Stock
May 01 2024	SELL Open market or private sale	$231,342 $20.37 p/Share	11,357 Reduced 100.0%	0 Common Stock
May 01 2024	BUY Exercise of conversion of derivative security	$21,400 $2.14 p/Share	10,000 Added 50.0%	10,000 Common Stock
Apr 16 2024	SELL Open market or private sale	$246,700 $24.67 p/Share	10,000 Reduced 100.0%	0 Common Stock
Apr 16 2024	BUY Exercise of conversion of derivative security	$21,400 $2.14 p/Share	10,000 Added 50.0%	10,000 Common Stock
Apr 01 2024	SELL Open market or private sale	$304,600 $30.46 p/Share	10,000 Reduced 100.0%	0 Common Stock

Apr 01 2024	BUY Exercise of conversion of derivative security	$21,400 $2.14 p/Share	10,000 Added 50.0%	10,000 Common Stock
Nov 01 2023	SELL Open market or private sale	$11,378 $10.42 p/Share	1,092 Reduced 100.0%	0 Common Stock
Jul 28 2023	SELL Open market or private sale	$98,604 $18.0 p/Share	5,478 Reduced 100.0%	0 Common Stock
Jul 28 2023	BUY Exercise of conversion of derivative security	$11,722 $2.14 p/Share	5,478 Added 50.0%	5,478 Common Stock
Jul 17 2023	SELL Open market or private sale	$81,893 $18.11 p/Share	4,522 Reduced 100.0%	0 Common Stock
Jul 17 2023	BUY Exercise of conversion of derivative security	$9,677 $2.14 p/Share	4,522 Added 50.0%	4,522 Common Stock
Jul 03 2023	SELL Open market or private sale	$180,000 $18.0 p/Share	10,000 Reduced 100.0%	0 Common Stock
Jul 03 2023	BUY Exercise of conversion of derivative security	$21,400 $2.14 p/Share	10,000 Added 50.0%	10,000 Common Stock
May 02 2023	SELL Open market or private sale	$14,656 $21.15 p/Share	693 Reduced 100.0%	0 Common Stock
May 01 2023	SELL Open market or private sale	$309,150 $20.61 p/Share	15,000 Reduced 95.58%	693 Common Stock
May 01 2023	BUY Exercise of conversion of derivative security	$32,100 $2.14 p/Share	15,000 Added 48.87%	15,693 Common Stock
Apr 03 2023	SELL Open market or private sale	$292,050 $19.47 p/Share	15,000 Reduced 100.0%	0 Common Stock
Apr 03 2023	BUY Exercise of conversion of derivative security	$32,100 $2.14 p/Share	15,000 Added 50.0%	15,000 Common Stock
Mar 01 2023	SELL Open market or private sale	$363,300 $24.22 p/Share	15,000 Reduced 100.0%	0 Common Stock
Mar 01 2023	BUY Exercise of conversion of derivative security	$32,100 $2.14 p/Share	15,000 Added 50.0%	15,000 Common Stock
Feb 01 2023	SELL Open market or private sale	$341,850 $22.79 p/Share	15,000 Reduced 100.0%	0 Common Stock
Feb 01 2023	BUY Exercise of conversion of derivative security	$32,100 $2.14 p/Share	15,000 Added 50.0%	15,000 Common Stock
Jan 03 2023	SELL Open market or private sale	$424,950 $28.33 p/Share	15,000 Reduced 100.0%	0 Common Stock

TPN

Timothy P Noyes

CHIEF EXECUTIVE OFFICER

Boston, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AVTE shares.

Notify only if

Value

Insider Trading

Get notified when an Aerovate Therapeutics, Inc. insider buys or sells AVTE shares.

Notify only if

Operation

Value

Type

News

Receive news related to Aerovate Therapeutics, Inc.

Track Activities on AVTE

Account